Mechanism of Action

We are motivated by patients in exploring the protection, resolution and repair system of the AT2-receptor and science is leading us in unlocking the full potential of our drug candidates, angiotensin II type 2 receptor agonists (ATRAGs).



Learn more about how ATRAGs promote alveolar repair and maintenance of alveolar integrity in idiopathic pulmonary fibrosis (IPF)